COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
MeVis publishes figures for financial year 2022/2023 and forecast for 2023/2024
MeVis Medical Solutions AG announces financial results for 2022/2023 with turnover down to €17.3 million and forecast for 2023/2024 with expected slight sales increase and stable EBIT. Details on sales, EBIT, and earnings provided -
-
COMMUNIQUÉ DE PRESSE
Fuller, Smith & Turner PLC: Transaction in Own Shares
Fuller, Smith & Turner PLC announces the purchase of 'A' ordinary shares as part of its share buyback program, acquiring 10,627 shares at an average price of 666.35p per share through Numis Securities Limited on the London Stock Exchange -
COMMUNIQUÉ DE PRESSE
ROSEN, A TOP RANKED LAW FIRM, Encourages Blue Ridge Bankshares, Inc. Investors with Losses to Secure Counsel Before Important February 5 Deadline in Securities Class Action Filed by the Firm - BRBS
Rosen Law Firm encourages Blue Ridge Bankshares, Inc. investors to secure counsel before the February 5 deadline in the securities class action filed by the Firm. Investors may be entitled to compensation without out of pocket fees -
COMMUNIQUÉ DE PRESSE
Audacia SAS: AUGMENTATION DES MOYENS ALLOUES AU CONTRAT DE LIQUIDITE CONCLU AVEC INVEST SECURITIES
Audacia SAS annonce l'augmentation des moyens alloués au contrat de liquidité avec INVEST SECURITIES, conformément à la décision AMF, afin d'améliorer la liquidité et d'éviter les décalages de cours non justifiés -
COMMUNIQUÉ DE PRESSE
Affluent Medical closes €3.5 million bridge via capital increase from key shareholders.
Affluent Medical closes €3.5 million bridge via capital increase from key shareholders. The transaction enables the company to continue exploring options for securing long-term financing and executing critical milestones. The bridge financing extends financial runway until May 2024 without impacting operational activities -
COMMUNIQUÉ DE PRESSE
Affluent Medical annonce la réalisation d'un financement relais de 3,5 millions d’euros par le biais d’une augmentation de capital souscrite par ses principaux actionnaires.
Affluent Medical a réalisé un financement relais de 3,5 millions d’euros à travers une augmentation de capital souscrite par ses actionnaires principaux, permettant de financer ses programmes cliniques et d'explorer des options de financement à long terme -
-
COMMUNIQUÉ RÉGLEMENTÉ
RAPPORT FINANCIER SEMESTRIEL 2023/2024
